Homozygous Familial Hypercholesterolemia Market is driven by innovative lipid-lowering therapies
Homozygous familial hypercholesterolemia (HoFH) is an inherited disorder characterized by extremely high low-density lipoprotein cholesterol (LDL-C) levels from birth, leading to early onset atherosclerosis and cardiovascular complications. The HoFH market comprises specialized therapeutics such as PCSK9 inhibitors, microsomal triglyceride transfer protein (MTP) inhibitors, antisense...
0 Comentários 0 Compartilhamentos 592 Visualizações 0 Anterior
Patrocinado

Affordable Web Hosting

Enjoy business benefit for affordable web hosting